WATCH THE LATEST FROM BIO 2026
Subscribe to Bio.News Weekly Newsletter
Get Bio.News in your inbox every Monday morning.
SubscribeNo spam. Just science. Unsubscribe at any time.
Latest News
Following court decision, Arkansas will not enforce Act 630 on drug distribution
On Tuesday July 28, the Arkansas State Board of Pharmacy suspended enforcement of a 2025 Arkansas law, Act 630, two...
BIO 2026: How biotechs break the $100M barrier in funding rounds
The tap is opening up for venture capital in the biotech industry. Venture investment in biotech jumped 23% year-over-year in...
BIO 2026: To restore trust in vaccines, listen to everyone’s concerns
Listening to people’s concerns about vaccines is key to helping them regain trust, according to experts promoting the need for...
BIO 2026: Realizing the promise of CAR-T cell therapies
“CAR-T cell therapies are remarkable drugs and are the gold standard for patients,” said Rachel Haurwitz, PhD, President & CEO...
FDA Advisory Committee to weigh whether to expand compounding of unapproved peptides
The FDA's Pharmacy Compounding Advisory Committee (PCAC) will consider this week whether seven unapproved peptides should be added to the...
BIO 2026: FDA leaders discuss restoring workforce, institutional knowledge
While the U.S. Food and Drug Administration (FDA) has faced significant change in recent years, industry leaders and agency officials...